Contract FA860621S0026
Princeton Biomeditech Corp · Department Of Defense · September 20, 2021
Princeton Biomeditech Corp was awarded a federal contract by Department Of Defense (Department Of The Air Force) on September 20, 2021 for $9.89 million of work in in-vitro diagnostic substance manufacturing. Performance is in Monmouth Junction, NJ. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on May 16, 2022.
Contract details
- PIID
- FA860621S0026
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition After Exclusion Of Sources
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
- Place of performance
- Monmouth Junction, NJ
- First action
- September 20, 2021
- Latest action
- May 16, 2022
Description
COVID-19 - INDUSTRIAL BASE EXPANSION
Modification timeline
-
May 16, 2022Mod P00001$0
-
September 20, 2021Base award$9.89M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Diasorin Inc | Department Of Defense | December 31, 2025 | $518.8K |
| Bloodworks | Department Of Defense | December 31, 2025 | $160.2K |
| Sl Meditech Co. | Department Of Defense | December 31, 2025 | $151.6K |
| Alba Bioscience, Inc. | Department Of Defense | December 31, 2025 | $163.2K |
| Werfen USA Llc | Department Of Defense | December 31, 2025 | $18.1K |
| Immucor Inc | Department Of Defense | December 31, 2025 | $154.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract FA860621S0026?
Contract FA860621S0026 is a federal contract awarded to Princeton Biomeditech Corp by Department Of Defense on September 20, 2021 for $9.89 million of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 1 time since the base award.
Who won contract FA860621S0026?
Princeton Biomeditech Corp won contract FA860621S0026 from Department Of Defense.
How much is contract FA860621S0026 worth?
Contract FA860621S0026 has obligated $9.89 million to date.